Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

ADAM-Afatinib Diarrhea Assessment and Management

NCT01814553

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1200.167.01009 Boehringer Ingelheim Investigational Site Santa Rosa, California, United States
  • 1200.167.01020 Boehringer Ingelheim Investigational Site Orlando, Florida, United States
  • 1200.167.01018 Boehringer Ingelheim Investigational Site Port Saint Lucie, Florida, United States
  • 1200.167.01012 Boehringer Ingelheim Investigational Site St. Petersburg, Florida, United States
View Trial Details
Completed

Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC

NCT00824408

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1230.5.00104 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada
  • 1230.5.00114 Boehringer Ingelheim Investigational Site Kelowna, British Columbia, Canada
  • 1230.5.00109 Boehringer Ingelheim Investigational Site Surrey, British Columbia, Canada
  • 1230.5.00107 Boehringer Ingelheim Investigational Site Vancouver, British Columbia, Canada
View Trial Details
Completed

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

NCT00035152

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Little Rock Hematology/Oncology Associates Little Rock, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Medical Oncology Care Associates Orange, California, United States
View all 56 locations
View Trial Details
Completed

LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations

NCT00525148

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1200.22.28 Boehringer Ingelheim Investigational Site Bakersfield, California, United States
  • 1200.22.32 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
  • 1200.22.4 Boehringer Ingelheim Investigational Site Mission Hills, California, United States
  • 1200.22.16 Boehringer Ingelheim Investigational Site Orange, California, United States
View all 30 locations
View Trial Details
Completed

ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

NCT00071188

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site Concord, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Boston, Massachusetts, United States
View all 34 locations
View Trial Details
Completed

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

NCT00059722

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Research Site Pine Bluff, Arkansas, United States
  • Research Site Los Angeles, California, United States
  • Research Site Palm Springs, California, United States
  • Research Site San Diego, California, United States
View all 48 locations
View Trial Details
Completed

BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)

NCT00656136

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1200.23.038 Boehringer Ingelheim Investigational Site Kingman, Arizona, United States
  • 1200.23.046 Boehringer Ingelheim Investigational Site Fayetteville, Arkansas, United States
  • 1200.23.027 Boehringer Ingelheim Investigational Site Anaheim, California, United States
  • 1200.23.028 Boehringer Ingelheim Investigational Site Berkeley, California, United States
View all 90 locations
View Trial Details
Completed

A Phase 1 Study in Participants With Advanced Cancer

NCT01115790

Conditions
Advanced Cancer, Anal Squamous Cell Carcinoma, Anus Diseases, +30 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Peggy and Charles Stephenson Oklahoma Cancer Center Oklahoma City, Oklahoma, United States
  • Sarah Cannon Research Institute SCRI Nashville, Tennessee, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
View Trial Details

Related conditions